<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03159169</url>
  </required_header>
  <id_info>
    <org_study_id>SJM-CIP-10194</org_study_id>
    <nct_id>NCT03159169</nct_id>
  </id_info>
  <brief_title>Treatment of Neck and Upper Limb Pain Using BurstDR (De Ridder) Stimulation</brief_title>
  <acronym>NU-BURST</acronym>
  <official_title>Treatment of Neck and Upper (NU) Limb Pain Using BurstDR Stimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Medical Devices</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Medical Devices</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, open label, multicenter feasibility study to evaluate the safety and&#xD;
      therapeutic efficacy of BurstDRTM SCS in treating chronic neck pain with or without radiation&#xD;
      down to arm/shoulder/upper back&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects diagnosed with chronic intractable neck pain with or without radiation down to&#xD;
      arm/shoulder/upper back will be considered for inclusion in this study. After baseline&#xD;
      evaluation, subjects will undergo a SCS trial using the Abbott Invisible Trial system. At the&#xD;
      end of the SCS trial, subjects experiencing at least 50% pain relief, according to average&#xD;
      neck VAS (calculated by the average of last 3 days on the pain diary), will be considered for&#xD;
      permanent implant and further participation in the study. Pain intensity, quality of life,&#xD;
      disability, headache severity, sleep quality, patient satisfaction, anxiety, depression,&#xD;
      stimulation sensation and medication usage assessments will be performed at baseline, after&#xD;
      SCS trial and at the 3, 6 and 12 month follow up visits.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 15, 2018</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analog Scale (VAS) for pain</measure>
    <time_frame>baseline</time_frame>
    <description>Golden standard self-evaluation of pain intensity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analog Scale for pain</measure>
    <time_frame>end of SCS trial (up to two weeks after electrodes implantation)</time_frame>
    <description>Golden standard self-evaluation of pain intensity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analog Scale for pain</measure>
    <time_frame>3 months post permanent implant</time_frame>
    <description>Golden standard self-evaluation of pain intensity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analog Scale for pain</measure>
    <time_frame>6 months post permanent implant</time_frame>
    <description>Golden standard self-evaluation of pain intensity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analog Scale for pain</measure>
    <time_frame>12 months post permanent implant</time_frame>
    <description>Golden standard self-evaluation of pain intensity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>EQ-5D - 5L (European Quality of Life) (5D-dimensions); (5L levels)</measure>
    <time_frame>baseline</time_frame>
    <description>Self reported questionnaire on quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5D - 5L</measure>
    <time_frame>End of SCS trial (up to two weeks after electrodes implantation)</time_frame>
    <description>Self reported questionnaire on quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5D - 5L</measure>
    <time_frame>3 months post permanent implant</time_frame>
    <description>Self reported questionnaire on quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5D - 5L</measure>
    <time_frame>6 months post permanent implant</time_frame>
    <description>Self reported questionnaire on quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5D - 5L</measure>
    <time_frame>12 months post permanent implant</time_frame>
    <description>Self reported questionnaire on quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ONDI</measure>
    <time_frame>baseline</time_frame>
    <description>Disability questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ONDI (Oswestry neck disability index)</measure>
    <time_frame>end of SCS trial (up to two weeks after electrodes implantation)</time_frame>
    <description>Disability questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ONDI</measure>
    <time_frame>3 months post permanent implant</time_frame>
    <description>Disability questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ONDI</measure>
    <time_frame>6 months post permanent implant</time_frame>
    <description>Disability questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ONDI</measure>
    <time_frame>12 months post permanent implant</time_frame>
    <description>Disability questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impression of Change</measure>
    <time_frame>end of SCS trial (up to two weeks after electrodes implantation)</time_frame>
    <description>questionnaire on patient satisfaction with therapeutic outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impression of Change</measure>
    <time_frame>3 months post permanent implant</time_frame>
    <description>questionnaire on patient satisfaction with therapeutic outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impression of Change</measure>
    <time_frame>6 months post permanent implant</time_frame>
    <description>questionnaire on patient satisfaction with therapeutic outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impression of Change</measure>
    <time_frame>12 months post permanent implant</time_frame>
    <description>questionnaire on patient satisfaction with therapeutic outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Headache Impact Test</measure>
    <time_frame>baseline</time_frame>
    <description>Questionnaire on headache burden</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Headache Impact Test</measure>
    <time_frame>end of SCS trial (up to two weeks after electrodes implantation)</time_frame>
    <description>Questionnaire on headache burden</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Headache Impact Test</measure>
    <time_frame>3 months post permanent implant</time_frame>
    <description>Questionnaire on headache burden</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Headache Impact Test</measure>
    <time_frame>6 months post permanent implant</time_frame>
    <description>Questionnaire on headache burden</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Headache Impact Test</measure>
    <time_frame>12 months post permanent implant</time_frame>
    <description>Questionnaire on headache burden</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression</measure>
    <time_frame>baseline</time_frame>
    <description>Questionnaire on anxiety and depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression</measure>
    <time_frame>end of SCS trial (up to two weeks after electrodes implantation)</time_frame>
    <description>Questionnaire on anxiety and depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression</measure>
    <time_frame>3 months post permanent implant</time_frame>
    <description>Questionnaire on anxiety and depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression</measure>
    <time_frame>6 months post permanent implant</time_frame>
    <description>Questionnaire on anxiety and depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression</measure>
    <time_frame>12 months post permanent implant</time_frame>
    <description>Questionnaire on anxiety and depression</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Neck Pain</condition>
  <condition>Upper Limb Pain</condition>
  <arm_group>
    <arm_group_label>study patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single arm study. Patients will receive Spinal Cord Stimulation (SCS) according to standard clinical procedures.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spinal Cord Stimulation (SCS)</intervention_name>
    <description>Implantation of SCS electrodes and stimulator according to clinical standards</description>
    <arm_group_label>study patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject is able to provide informed consent to participate in the study;&#xD;
&#xD;
          -  Subject is 18 years of age or older;&#xD;
&#xD;
          -  Subject has failed to respond to at least 6 months of conventional treatment which may&#xD;
             include pharmacological treatment, physical therapy, and injections;&#xD;
&#xD;
          -  Subject has failed to respond to medial branch blocks;&#xD;
&#xD;
          -  Subject diagnosed with chronic predominant intractable neck pain with or without&#xD;
             radiation down to arm/shoulder/upper back;&#xD;
&#xD;
          -  Subject has neck pain intensity of at least 6.0 cm out of 10.0 cm on the average neck&#xD;
             pain VAS at baseline (according to the last 3 days of the baseline pain diary);&#xD;
&#xD;
          -  Subject is on stable pain medications with a total opioid equivalent of120 mg or less&#xD;
             for at least 28 days prior to enrolling in this study, and is willing to stay on those&#xD;
             medications with no dose increase until activation of the permanently implanted SCS&#xD;
             device;&#xD;
&#xD;
          -  Subject's medical record has been evaluated by the Investigator to ensure that the&#xD;
             subject is a good candidate for a neurostimulation system;&#xD;
&#xD;
          -  Subject is willing to cooperate with the study requirements including compliance with&#xD;
             the regimen and completion of all office visits;&#xD;
&#xD;
          -  Female candidates of child-bearing potential agree to commit to the use of an&#xD;
             effective method of contraception (including but not limited to sterilization, barrier&#xD;
             devices, oral contraceptives, intrauterine devices (IUDs), condoms, rhythm method, or&#xD;
             abstinence) for the duration of the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject has a current diagnosis of a coagulation disorder, bleeding diathesis,&#xD;
             progressive peripheral vascular disease, moderate or severe cervical stenosis&#xD;
             determined by existing or new MRI scan performed as part of standard of care,&#xD;
             mechanical neck pain originating from cervical facet joint syndrome, post-herpetic&#xD;
             neuralgia, spondylolisthesis, retrolisthesis, CRPS (Chronic Regional Pain Syndrome) or&#xD;
             uncontrolled diabetes mellitus;&#xD;
&#xD;
          -  Subject with significant scoliosis even if surgically corrected;&#xD;
&#xD;
          -  Subject is currently participating in a clinical investigation that includes an active&#xD;
             treatment arm;&#xD;
&#xD;
          -  Subject has been implanted with or participated in a trial period for a&#xD;
             neurostimulation system;&#xD;
&#xD;
          -  Subject has an infusion pump;&#xD;
&#xD;
          -  Subject has evidence of an active disruptive psychological or psychiatric disorder as&#xD;
             determined as per standard of care;&#xD;
&#xD;
          -  Subject has a current diagnosis of a progressive neurological disease as determined by&#xD;
             the Investigator;&#xD;
&#xD;
          -  Subject is immunocompromised;&#xD;
&#xD;
          -  Subject has an existing medical condition that is likely to require repetitive MRI&#xD;
             evaluation in the future (i.e. epilepsy, stroke, multiple sclerosis, acoustic neuroma,&#xD;
             tumor);&#xD;
&#xD;
          -  Subject has history of cancer requiring active treatment in the last 12 months;&#xD;
&#xD;
          -  Subject has an existing medical condition that is likely to require the use of&#xD;
             diathermy in the future;&#xD;
&#xD;
          -  Subject has documented history of allergic response to titanium or silicone;&#xD;
&#xD;
          -  Subject has a documented history of substance abuse (narcotics, alcohol, etc.) or&#xD;
             substance dependency in the 6 months prior to baseline data collection;&#xD;
&#xD;
          -  Subject is a female candidates of child bearing potential that are pregnant (confirmed&#xD;
             by positive urine/blood pregnancy test);&#xD;
&#xD;
          -  Subject has life expectancy of less than 1 year;&#xD;
&#xD;
          -  Subject is involved in an injury claim under current litigation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adnan Al-Kaisy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guy's St. Thomas</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lalit Venkatesan, Ph.D.</last_name>
    <phone>+19723098522</phone>
    <email>LVenkatesan@sjm.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Filippo Agnesi, Ph.D.</last_name>
    <phone>+19725264860</phone>
    <email>FAgnesi@sjm.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Southmead hospital</name>
      <address>
        <city>Bristol</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann Rich</last_name>
      <email>Ann.Rich@nbt.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Nik Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sarah Love-Jones, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guy's St. Thomas Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samuel Wesley</last_name>
      <phone>02071 883237</phone>
      <email>Samuel.Wesley@gstt.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Adnan Al-Kaisy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stefano Palmisani, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Pang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Southampton NHS Foundation Trust</name>
      <address>
        <city>Southampton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Beveridge</last_name>
      <email>Michelle.Beveridge@uhs.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Girish Vajramani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>May 11, 2017</study_first_submitted>
  <study_first_submitted_qc>May 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2017</study_first_posted>
  <last_update_submitted>April 6, 2021</last_update_submitted>
  <last_update_submitted_qc>April 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neck Pain</keyword>
  <keyword>Upper Limb Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neck Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

